MX2021010555A - Derivados carbocíclicos y derivados conjugados de los mismos y su uso en vacunas. - Google Patents
Derivados carbocíclicos y derivados conjugados de los mismos y su uso en vacunas.Info
- Publication number
- MX2021010555A MX2021010555A MX2021010555A MX2021010555A MX2021010555A MX 2021010555 A MX2021010555 A MX 2021010555A MX 2021010555 A MX2021010555 A MX 2021010555A MX 2021010555 A MX2021010555 A MX 2021010555A MX 2021010555 A MX2021010555 A MX 2021010555A
- Authority
- MX
- Mexico
- Prior art keywords
- derivatives
- vaccines
- carbocyclic
- conjugate
- oligomers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19161716 | 2019-03-08 | ||
| PCT/EP2020/055950 WO2020182635A1 (en) | 2019-03-08 | 2020-03-06 | Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021010555A true MX2021010555A (es) | 2022-04-06 |
Family
ID=66000932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021010555A MX2021010555A (es) | 2019-03-08 | 2020-03-06 | Derivados carbocíclicos y derivados conjugados de los mismos y su uso en vacunas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220152183A1 (https=) |
| EP (1) | EP3934696A1 (https=) |
| JP (2) | JP7728704B2 (https=) |
| CN (1) | CN114126662A (https=) |
| BR (1) | BR112021017239A2 (https=) |
| CA (1) | CA3131741A1 (https=) |
| MX (1) | MX2021010555A (https=) |
| WO (1) | WO2020182635A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202115151D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| GB0220198D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Modified saccharides,conjugates thereof and their manufacture |
| ES2461350T3 (es) | 2003-01-30 | 2014-05-19 | Novartis Ag | Vacunas inyectables contra múltiples serogrupos de meningococos |
| GB0409750D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| JP6786394B2 (ja) | 2014-02-28 | 2020-11-18 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 改変髄膜炎菌ｆＨｂｐポリペプチド |
| GB202013262D0 (en) * | 2020-08-25 | 2020-10-07 | Glaxosmithkline Biologicals Sa | Vaccine Composition |
-
2020
- 2020-03-06 EP EP20708099.5A patent/EP3934696A1/en active Pending
- 2020-03-06 MX MX2021010555A patent/MX2021010555A/es unknown
- 2020-03-06 JP JP2021552816A patent/JP7728704B2/ja active Active
- 2020-03-06 CN CN202080031171.4A patent/CN114126662A/zh active Pending
- 2020-03-06 US US17/436,692 patent/US20220152183A1/en active Pending
- 2020-03-06 WO PCT/EP2020/055950 patent/WO2020182635A1/en not_active Ceased
- 2020-03-06 BR BR112021017239A patent/BR112021017239A2/pt unknown
- 2020-03-06 CA CA3131741A patent/CA3131741A1/en active Pending
-
2025
- 2025-03-25 JP JP2025050172A patent/JP2025111445A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025111445A (ja) | 2025-07-30 |
| EP3934696A1 (en) | 2022-01-12 |
| JP2022523570A (ja) | 2022-04-25 |
| US20220152183A1 (en) | 2022-05-19 |
| WO2020182635A1 (en) | 2020-09-17 |
| CN114126662A (zh) | 2022-03-01 |
| JP7728704B2 (ja) | 2025-08-25 |
| BR112021017239A2 (pt) | 2021-11-09 |
| CA3131741A1 (en) | 2020-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024006606A (es) | Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y metodos de uso de estos. | |
| CL2020000501A1 (es) | Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp1) y usos de los mismos. | |
| CL2021000405A1 (es) | Moduladores de calpaínas y usos terapeuticos de los mismos (divisional sol. 201900793) | |
| CL2021000901A1 (es) | Enlazadores de conjugación que contienen el grupo 2,3-diaminosuccinilo | |
| MX2025007999A (es) | Conjugados de interleucina-2 (il-2) | |
| CO2019002955A2 (es) | Composiciones de vacuna neumocócica multivalente que comprenden conjugados de polisacáridos y proteínas | |
| CL2018002803A1 (es) | Antagonistas de c5ar solubles | |
| MX2018013640A (es) | Liposomas pegiladas y metodos de uso. | |
| CO2017010191A2 (es) | Éteres de celulosa esterificados solubles en agua que tienen grado bajo de neutralización | |
| MX386738B (es) | Producto para el cuidado bucal y métodos de uso y fabricación de este. | |
| PE20190328A1 (es) | Compuestos de carfilzomib pegilados | |
| UY38016A (es) | Oligonucleótidos inmunoestimulantes | |
| PY1889910A (es) | Composiciones de vacuna estables que comprenden inter alia un flavivirus recombinante atenuado vivo y proceso para la preparación de las mismas | |
| IL311855A (en) | Immunogenic lnp compositions and methods thereof | |
| CO2021009379A2 (es) | Formulaciones y métodos de la vacuna contra el norovirus | |
| MX2022010051A (es) | Polimeros anfifilicos y su uso para mejorar la produccion de nanoparticulas para el suministro dirigido de antigenos. | |
| CO2017007057A2 (es) | Vacuna contra la fiebre aftosa | |
| BR112023021812A2 (pt) | Composição vacinal adjuvantada e métodos | |
| MX2021010555A (es) | Derivados carbocíclicos y derivados conjugados de los mismos y su uso en vacunas. | |
| IL312965A (en) | Immunogenic compositions and their uses | |
| UY35418A (es) | Vacuna que proporciona protección frente a diferentes Picornavirus humanos. | |
| MX2024003230A (es) | Composiciones de tiostrepton y preparacion de estas. | |
| MX2021014806A (es) | Composiciones para el cuidado bucal y sus usos. | |
| CL2020002195A1 (es) | Ehv novedoso con ul18 y/o ul8 inactivados | |
| IL321069A (en) | Pneumococcal conjugate vaccine preparations |